AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q4 2018

SEC EDGAR SourceSEC Filings

Top Holdings2,175 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

20.2M$2B2.4%$93.930.00%
1 qtr
New
83

APPLE INC

8.4M$1.3B1.5%$37.390.00%
1 qtr
New
73

PFIZER INC

27.2M$1.2B1.4%$28.590.00%
1 qtr
New
73

MERCK & CO. INC.

13.1M$999.3M1.2%$57.900.00%
1 qtr
New
73

BIOGEN IDEC INC

3.2M$949.7M1.1%$300.920.00%
1 qtr
New
73

AMAZON.COM INC

620,035$931.3M1.1%$73.900.00%
1 qtr
New
73

WALMART INC

9.8M$914.8M1.1%$27.660.00%
1 qtr
New
73

META PLATFORMS INC-CLASS A

6.8M$896.7M1.0%$132.280.00%
1 qtr
New
73

JOHNSON & JOHNSON

6.6M$857.8M1.0%$104.550.00%
1 qtr
New
62

INTEL CORP

18.2M$852.7M1.0%$40.230.00%
1 qtr
New
62

ADOBE INC

3.7M$840.6M1.0%$226.240.00%
1 qtr
New
62

EXELON CORP

17.8M$801.5M0.9%$24.960.00%
1 qtr
New
62

HUMANA INC

2.7M$778.9M0.9%$265.720.00%
1 qtr
New
62

ANTHEM INC

3M$778.2M0.9%$236.130.00%
1 qtr
New
62

ALPHABET INC-CL A

717,294$749.5M0.9%$51.940.00%
1 qtr
New
62

MICRON TECHNOLOGY INC

22.9M$725.1M0.8%$30.800.00%
1 qtr
New
62

THE CIGNA GROUP

3.7M$708.4M0.8%$171.720.00%
1 qtr
New
62

ALLSTATE CORP

8.3M$686.2M0.8%$69.390.00%
1 qtr
New
62
RTNRTNDelisted

RAYTHEON CO

4.3M$656.6M0.8%
1 qtr
New
62

BOEING CO/THE

2M$648.9M0.8%$313.370.00%
1 qtr
New
62
$86.3B
AUM
2,175
Positions
Q4 2018
Filing
Rating · 2.0
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q4'18
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

AQR CAPITAL MANAGEMENT LLC manages $86.3B across 2175 positions as of Q4 2018. Top holdings: MSFT (2.4%), AAPL (1.5%), PFE (1.4%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 2/5.0.

Q4 2018 Summary

Active quarter - 2175 new positions, 0 exits, 0 increased. Top move: MSFT (NEW, conviction 83). Portfolio: $86.3B across 2175 positions.

Top holdings by portfolio weight

Total AUM$86B
MSFT2.37%
AAPL1.54%
PFE1.38%
MRK1.16%
BIIB1.10%
AMZN1.08%
WMT1.06%
META1.04%
JNJ0.99%
INTC0.99%
Other0.97%

Portfolio allocation by GICS sector

Sectors11
Healthcare18.68%
Technology16.81%
Consumer Cyclical12.55%
Unknown10.49%
Financial Services9.29%
Industrials8.29%
Consumer Defensive6.90%
Communication Services5.22%
Utilities4.51%
Energy3.73%
Other3.51%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Technology, Consumer Cyclical
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record61
Conviction42
Concentration18
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
AGNCAGNCAGNC INVESTMENT CORP
Q3 2024 Q2 2026+330,375 shares+$3.6M
8Q
ALRMALRMALARM COM HLDGS INC
Q3 2024 Q2 2026+219,398 shares+$9.5M
8Q
BSVOBSVOEA SERIES TRUST
Q3 2024 Q2 2026+929,011 shares+$27.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used